Bristol-Myers Squibb Company (NYSE:BMY)

Bristol-Myers Squibb Company is a global leader in the research and development of innovative lifesaving and life-enhancing treatments for heart disease; high blood pressure; stroke; diabetes; cancer; HIV/AIDS and other infectious diseases; depression, schizophrenia and other mental disorders; pain; and other conditions.

Bristol-Myers Squibb Company (NYSE:BMY)’s Financial Overview

Bristol-Myers Squibb Company (NYSE:BMY) declined -0.27% yesterday to close its trading session at $56.36. The company has 1 year Price Target of $62.74. Bristol-Myers Squibb Company has 52-Week high of $77.12 and 52-Week Low of $49.03. The stock touched its 52-Week High on Jul 15, 2016 and 52-Week Low on Oct 25, 2016. The stock traded with the volume of 9.82 Million shares yesterday. The firm shows the market capitalization of $94.19 Billion.

Bristol-Myers Squibb Company (NYSE:BMY) reported its last quarterly earnings on Sep 16 where the firm reported its Actual EPS of $0.77/share against the analyst consensus estimate of $0.65/share. The difference between the actual and expected EPS is $0.12 a share with a surprise factor of 18.5%.

The firm is trading with SMA20 of 2.94 Percent, SMA50 of 5.57 Percent and SMA200 of -11.03 percent. Bristol-Myers Squibb Company has P/S value of 5.1 while its P/B value stands at 6.03. Similarly, the company has Return on Assets of 10.3 percent, Return on Equity of 22.7 percent and Return on Investment of 4.6 Percent. The company shows Gross Margin and Operating Margin of 75.7 percent and 24.7 percent respectively.

Many brokerage firms are involved in issuing their ratings on Bristol-Myers Squibb Company (NYSE:BMY). On 11-Aug-16 Berenberg Downgrade Bristol-Myers Squibb Company Stock  to Hold. Another firm also rated the stock on 8-Aug-16 where Credit Suisse Downgrade the stock to Neutral.

The Stock currently has Analyst’ mean Recommendation of 2.5 where the scale is from 1 to 5, 1 means Strong Buy and 5 means Sell.

The 23 analysts offering 12-month price forecasts for Bristol-Myers Squibb have a median target of 61.00, with a high estimate of 100.00 and a low estimate of 44.20. The median estimate represents a +8.23% increase from the last price of 56.36.

Our vendor, Zacks Investment Research, hasn’t provided us with the upcoming earnings report date.

SeaDrill Limited (NYSE:SDRL)

Seadrill Limited is an international offshore drilling contractor providing drilling and well services. Seadrill’s versatile fleet includes harsh-environment semi-submersibles, jack-ups, shallow and deep water tender rigs and deepwater drill ships. In addition, the Company provides platform drilling, well intervention and engineering services. Seadrill Limited is based in Hamilton, Bermuda.

SeaDrill Limited (NYSE:SDRL)’s Financial Outlook

The 21 analysts offering 12-month price forecasts for Seadrill Ltd have a median target of 1.22, with a high estimate of 4.14 and a low estimate of 0.12. The median estimate represents a -50.15% decrease from the last price of 2.45.

Our vendor, Zacks Investment Research, hasn’t provided us with the upcoming earnings report date.

According to Zacks Investment Research, SeaDrill Limited has a Consensus Recommendation of 4.17. (The Scale is from 1-5 where 1 means Strong Buy and 5 means Strong Sell).

The Stock fell -3.92% and closed its last trading session at $2.45. The company has the market capitalization of $1.16 Billion. The stock has 52-week high of $7.49 and 52-Week low of $1.57. The firm touched its 52-Week high on Mar 4, 2016 and 52-Week low on Feb 11, 2016. The company has volume of 9.79 Million shares. The company has a total of 475.29 Million shares outstanding.

SeaDrill Limited (NYSE:SDRL) in the last quarter reported its actual EPS of $0.36/share where the analyst estimated EPS was $0.22/share. The difference between the actual and Estimated EPS is $0.14. This shows a surprise factor of 63.6 percent.

The company has YTD performance of -27.73 percent. Beta for SeaDrill Limited stands at 2.63 while its ATR (average true range) is 0.17. The company has Weekly Volatility of 10.83%% and Monthly Volatility of 7.11%%.

SeaDrill Limited has distance from 20-day Simple Moving Average (SMA20) of 8.17%, Distance from 50-Day Simple Moving Average of 6 percent and Distance from 200-Day Simple Moving Average of -17.31%.

The Company currently has ROA (Return on Assets) of -0.2 percent, Return on Equity (ROE) of -0.4 Percent and Return on Investment (ROI) of -2.2% with Gross margin of 64.6 percent and Operating & Profit margin of 8.8% and -1.1% respectively.